Npgrj_Nbt_1390 326..334

We report a method of inducing antigen production in dendritic cells by in vivo targeting with lentiviral vectors that specifically bind to the dendritic cell–surface protein DC-SIGN. To target dendritic cells, we enveloped the lentivector with a viral glycoprotein from Sindbis virus engineered to be DC-SIGN–specific. In vitro, this lentivector specifically transduced dendritic cells and induced dendritic cell maturation. A high frequency (up to 12%) of ovalbumin (OVA)-specific CD8+ T cells and a significant antibody response were observed 2 weeks after injection of a targeted lentiviral vector encoding an OVA transgene into naive mice. This approach also protected against the growth of OVA-expressing E.G7 tumors and induced regression of established tumors. Thus, lentiviral vectors targeting dendritic cells provide a simple method of producing effective immunity and may provide an alternative route for immunization with protein antigens.

[1]  Franco Patrone,et al.  The use of dendritic cells in cancer immunotherapy. , 2008, Critical reviews in oncology/hematology.

[2]  Carl G. Figdor,et al.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting , 2007, Nature Reviews Immunology.

[3]  J. Aerts,et al.  Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics , 2007, Gene Therapy.

[4]  G. Nabel,et al.  Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells , 2007, PLoS pathogens.

[5]  K. Slawin,et al.  An essential role for Akt1 in dendritic cell function and tumor immunotherapy , 2006, Nature Biotechnology.

[6]  Li Hao,et al.  DC-SIGN and immunoregulation. , 2006, Cellular & molecular immunology.

[7]  D. Baltimore,et al.  Targeting lentiviral vectors to specific cell types in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Maureen E. Taylor,et al.  Widely Divergent Biochemical Properties of the Complete Set of Mouse DC-SIGN-related Proteins* , 2006, Journal of Biological Chemistry.

[9]  J. Aerts,et al.  Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors , 2006, Gene Therapy.

[10]  R. Steinman,et al.  Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine , 2006, The Journal of experimental medicine.

[11]  C. Figdor,et al.  Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses , 2006, The Journal of Immunology.

[12]  Simon C Watkins,et al.  Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine. , 2005, Human gene therapy.

[13]  A. Palucka,et al.  Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.

[14]  D. Baltimore,et al.  Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Nabel,et al.  Adenovirus vector-based vaccines for human immunodeficiency virus type 1. , 2005, Human gene therapy.

[16]  Lily Wu,et al.  Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection , 2005, Nature Medicine.

[17]  Lei Shen,et al.  Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity , 2004, Nature Biotechnology.

[18]  Hildegund C.J. Ertl,et al.  Adenoviruses as vaccine vectors , 2004, Molecular Therapy.

[19]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[20]  R. Steinman,et al.  Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins. , 2004, International immunology.

[21]  C. Figdor,et al.  Dendritic cell immunotherapy: mapping the way , 2004, Nature Medicine.

[22]  T. Geijtenbeek,et al.  Self- and nonself-recognition by C-type lectins on dendritic cells. , 2004, Annual review of immunology.

[23]  R. Steinman,et al.  In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.

[24]  J. Shiver,et al.  Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. , 2004, Annual review of medicine.

[25]  William B. Klimstra,et al.  DC-SIGN and L-SIGN Can Act as Attachment Receptors for Alphaviruses and Distinguish between Mosquito Cell- and Mammalian Cell-Derived Viruses , 2003, Journal of Virology.

[26]  R. Schroers,et al.  Lentiviral transduction of human dendritic cells. , 2004, Methods in molecular biology.

[27]  D. Curiel,et al.  Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells , 2003, Journal of Virology.

[28]  I. Miconnet,et al.  In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. , 2003, The Journal of clinical investigation.

[29]  Michel C. Nussenzweig,et al.  Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance , 2002, The Journal of experimental medicine.

[30]  Andy Smith.  Mapping the way , 2002, Trends in Neurosciences.

[31]  D. Curiel,et al.  Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors1 , 2002, The Journal of Immunology.

[32]  E. Rieber,et al.  Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34+ cord blood-derived dendritic cells , 2002, Gene Therapy.

[33]  P. Romero,et al.  Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. , 2002, Human gene therapy.

[34]  A. Ribas,et al.  Cancer immunotherapy using gene-modified dendritic cells. , 2002, Current gene therapy.

[35]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[36]  Frederic D. Bushman,et al.  A quantitative assay for HIV DNA integration in vivo , 2001, Nature Medicine.

[37]  W. Song,et al.  Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen , 2000, Gene Therapy.

[38]  S. Rose-John,et al.  Generation of Tumor-Reactive CTL Against the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells Derived from CD34+ Hemopoietic Progenitor Cells1 , 2000, The Journal of Immunology.

[39]  P. Mangeot,et al.  Development of Minimal Lentivirus Vectors Derived from Simian Immunodeficiency Virus (SIVmac251) and Their Use for Gene Transfer into Human Dendritic Cells , 2000, Journal of Virology.

[40]  J. Mulé,et al.  Gene-modified dendritic cells for use in tumor vaccines. , 2000, Human gene therapy.

[41]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[42]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[43]  J. Kaplan,et al.  Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. , 1999, Journal of immunology.

[44]  D. Griffin,et al.  Binding of Sindbis Virus to Cell Surface Heparan Sulfate , 1998, Journal of Virology.

[45]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[46]  Y. Uehara,et al.  A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph , 1996, The Journal of experimental medicine.

[47]  J. H. Strauss,et al.  Host-cell receptors for Sindbis virus. , 1994, Archives of virology. Supplementum.